Revista Científica Multidisciplinaria Arbitrada YACHASUN. Volumen 10, Número 19 (Ed. jul – dic. 2026) ISSN: 2697-3456

Fat embolism syndrome after femoral fracture: early recognition, diagnostic confirmation, and therapeutic strategy.

DOI: https://doi.org/10.46296/yc.v10i19.0965

SÍNDROME DE EMBOLIA GRASA TRAS FRACTURA FEMORAL:

RECONOCIMIENTO PRECOZ, CONFIRMACIÓN DIAGNÓSTICA Y

ESTRATEGIA TERAPÉUTICA

FAT EMBOLISM SYNDROME AFTER FEMORAL FRACTURE: EARLY

RECOGNITION, DIAGNOSTIC CONFIRMATION, AND THERAPEUTIC

STRATEGY

1

2

Macias-Narvaez Kevin Eduardo ; Sánchez-Macas Carlos Patricio ; Valle-Castillo

5

Alejandro Israel ; Bailón-Pinargote Dianella Carolina ; Pineda-Morocho Hugo Xavier

3

4

1

Médico General, Machala. El Oro, Ecuador.

Correo: kevinmaciasnarvaez2@gmail.com. ORCID ID: https://orcid.org/0009-0000-3745-1647

2

Médico General. Loja, Ecuador. Correo : carlos_sanchez199674@outlook.com.

ORCID ID: https://orcid.org/0000-0002-3071-3728

3

Medico General, Hospital Manuel Ygnacio Monteros – IESS. Loja, Ecuador.

Correo: alejandrovalle010@gmail.com. ORCID ID: https://orcid.org/0009-0009-3954-2767

4

Licenciada Laboratorio Clínico. Manta, Ecuador.

Correo: dianellabailon12@gmail.com. ORCID ID: https://orcid.org/0009-0003-7022-638X

5

Médico General, Consultorio Médico Privado. Ecuador.

Correo: hugoxavierpineda@gmail.com. ORCID ID: https://orcid.org/0009-0005-4176-1310

Resumen

Introducción: El síndrome de embolia grasa (SEG) es una complicación infrecuente pero

potencialmente mortal de las fracturas femorales y de otros huesos largos. No existe una prueba

diagnóstica patrón oro validada y la tríada clásica de hipoxemia, deterioro neurológico y

petequias suele ser incompleta. Métodos: Se realizó una actualización multidominio de la

evidencia hasta el 30 de agosto de 2026. La base epidemiológica histórica se apoyó en una

revisión sistemática previa de fracturas femorales (1960–2019) y se complementó mediante

búsquedas en PubMed/MEDLINE, PubMed Central y rastreo de referencias para identificar

cohortes contemporáneas, estudios diagnósticos, ensayos aleatorizados y síntesis de alta

relevancia. La heterogeneidad impidió un nuevo metaanálisis. Resultados: La revisión histórica

incluyó 15 estudios (n=3.095) y mostró una reducción de la incidencia clínica desde 7,9% en

1960–1979 hasta 1,7% en 2000–2019. Cohortes administrativas contemporáneas informan

incidencias codificadas de 0,03–0,04%, mientras que una cohorte de centro de trauma de 2026

informó 4,3%. La fractura femoral, las fracturas múltiples, la edad joven y el trauma de alta

energía aumentan el riesgo. La hipoxemia de nueva aparición y el deterioro neurológico durante

las primeras 12–72 h constituyen las señales más útiles. La RM cerebral con DWI y SWI aporta

el mayor apoyo radiológico en el SEG cerebral. El tratamiento se basa en soporte orgánico y

estabilización oportuna de la fractura. Los corticoides profilácticos muestran una señal de

beneficio en ensayos antiguos, pero sin evidencia robusta de reducción de mortalidad.

Conclusiones: El SEG debe considerarse un diagnóstico clinicorradiológico de exclusión y de

reconocimiento urgente. La vigilancia durante las primeras 72 h, la investigación temprana de

hipoxemia o deterioro neurológico, el uso selectivo de RM y el soporte crítico moderno

constituyen la estrategia más sólida. No existe evidencia suficiente para recomendar

anticoagulación específica o corticoides de rutina para el SEG establecido.

Palabras claves: síndrome de embolia grasa; fractura de fémur; fractura de huesos largos;

hipoxemia; embolia grasa cerebral; resonancia magnética; fijación de fracturas; trauma.

Información del manuscrito:

Fecha de recepción: 17 de abril de 2026.

Fecha de aceptación: 22 de junio de 2026.

Fecha de publicación: 10 de julio de 2026.

8

21

Macias-Narvaez et al. (2026)

Abstract

Background: Fat embolism syndrome (FES) is an uncommon but potentially life-threatening

complication of femoral and other long-bone fractures. Its diagnosis remains difficult because no

validated gold-standard test exists, and the classic triad of hypoxemia, neurologic dysfunction,

and petechiae is often incomplete. This updated systematic review summarizes evidence relevant

to early recognition, diagnostic confirmation, prevention, and treatment. Methods: A multidomain

evidence update was performed through 30 August 2026. The historical epidemiologic evidence

base was anchored to a prior systematic review of femoral fractures (1960–2019), and

PubMed/MEDLINE, PubMed Central, and backward citation searches were used to identify

contemporary cohort, diagnostic, randomized, and high-value synthesis studies. Evidence was

synthesized qualitatively because diagnostic definitions, populations, and interventions were

heterogeneous. Results: The historical review included 15 studies (n=3,095) and documented a

fall in clinically diagnosed FES from 7.9% in 1960–1979 to 1.7% in 2000–2019. Contemporary

administrative cohorts report much lower coded incidence (approximately 0.03–0.04%), whereas

a 2026 trauma-center cohort reported 4.3%, highlighting persistent case-definition effects.

Femoral fracture, multiple long-bone fractures, younger age, and high-energy trauma consistently

increase risk. New hypoxemia and neurologic deterioration within 12–72 h are the most useful

early signals; petechiae are specific when present but insensitive. Gurd–Wilson and Schonfeld

criteria remain supportive rather than confirmatory. Chest CT can demonstrate bilateral ground-

glass or centrilobular opacities but is nonspecific; brain MRI with diffusion-weighted imaging and

susceptibility-weighted imaging provides the strongest imaging support for cerebral FES.

Bronchoalveolar lavage fat-laden macrophages lack adequate specificity. The therapeutic

cornerstone is organ support and timely fracture stabilization when physiologically appropriate.

Older randomized trials suggest that prophylactic corticosteroids reduce FES and hypoxemia, but

the evidence is small, dated, and methodologically limited, with no proven mortality benefit.

Conclusions: FES should be treated as a time-sensitive clinicoradiologic diagnosis of exclusion.

A structured first-72-hour surveillance strategy, early investigation of unexplained hypoxemia or

neurologic change, selective MRI confirmation, and modern supportive critical care offer the most

defensible approach. Routine disease-specific anticoagulation or corticosteroid therapy for

established FES cannot be recommended from current evidence.

Keywords: fat embolism syndrome; femoral fracture; long-bone fracture; hypoxemia; cerebral fat

embolism; magnetic resonance imaging; fracture fixation; trauma.

setting because of the large

1

. Introduction

intramedullary fat reservoir and the

high-energy mechanisms that often

accompany shaft fractures and

polytrauma. [1–4]

Fat embolization is frequent after

major skeletal trauma, but the clinical

fat embolism syndrome (FES) is

much less common. The distinction

is clinically important: circulating

marrow fat or intraoperative embolic

showers can occur without organ

dysfunction, whereas FES denotes a

FES remains diagnostically difficult

more than five decades after the

original criteria proposed by Gurd

and later modified with Wilson. [1,2]

No biomarker, imaging sign, or

systemic

inflammatory

and

clinical

score

has

adequate

microvascular syndrome dominated

by respiratory and neurologic injury.

Femoral fractures are the prototypic

sensitivity and specificity to function

as a stand-alone reference standard.

8

22

Revista Científica Multidisciplinaria Arbitrada YACHASUN. Volumen 10, Número 19 (Ed. jul – dic. 2026) ISSN: 2697-3456

Fat embolism syndrome after femoral fracture: early recognition, diagnostic confirmation, and therapeutic strategy.

Consequently, published incidence

varies widely according to

2. Methods

2

.1 Review design and reporting

population, diagnostic definition,

timing of surveillance, and whether

cases are identified prospectively,

This manuscript was designed as an

updated systematic review with

narrative clinical synthesis. PRISMA

clinically,

radiologically,

administratively, or at autopsy. A

systematic review of femoral-fracture

studies demonstrated a marked

temporal decline in incidence, but

contemporary datasets continue to

produce estimates ranging from

hundredths of a percent to several

percent. [3–7]

2

020 principles were applied where

compatible with an evidence update

spanning

epidemiology/risk,

confirmation,

several

domains

(

diagnostic

prevention,

and

treatment). Because the included

literature uses nonuniform definitions

of FES and markedly different study

designs, no new pooled meta-

analysis was performed. The

protocol was not prospectively

registered; this is acknowledged as a

limitation and should be considered

when interpreting the review.

The practical problem is therefore not

simply whether FES exists, but how

to recognize it before severe

hypoxemic respiratory failure or

cerebral

involvement

becomes

established, how to use imaging

without overdiagnosing nonspecific

trauma-related changes, and which

therapeutic measures are supported

by evidence. The objective of this

updated systematic review and

evidence synthesis was to integrate

2

.2 Evidence sources and search

strategy

The historical epidemiologic and

fracture-management evidence base

was anchored to the systematic

review by Lempert et al., which

the

epidemiologic,

diagnostic,

searched

MEDLINE,

Embase,

preventive, and therapeutic literature

relevant to FES after femoral fracture

and to translate it into a clinically

usable pathway.

PubMed, and the Cochrane Central

Register of Controlled Trials for

studies published from 1960 through

3

1

1 December 2019 and screened

,024 records, of which 15 studies

8

23

Macias-Narvaez et al. (2026)

(

n=3,095) were included. [3] An

information not available from higher-

level evidence.

update was then undertaken through

3

0

August

2026

using

2

.3 Eligibility criteria

PubMed/MEDLINE,

PubMed

Central, targeted journal searches,

and backward citation searching.

Search concepts combined “fat

embolism syndrome,” “fat embolism,”

Eligible evidence

involved

adolescents or adults with traumatic

femoral or other major long-bone

fractures and reported at least one of

the following: incidence or risk

factors for FES; timing or clinical

presentation; performance or clinical

utility of diagnostic criteria, laboratory

“femur,” “femoral fracture,” “long-

bone fracture,” “early fixation,”

“intramedullary nailing,” “diagnosis,”

“

Gurd,”

“Schonfeld,”

imaging,”

“magnetic

resonance

“diffusion-

findings,

chest

imaging,

weighted imaging,” “susceptibility-

neuroimaging, or bronchoalveolar

lavage; fracture stabilization as a

preventive strategy; pharmacologic

prophylaxis or treatment; critical-care

support; or outcomes. Randomized

trials, prospective and retrospective

weighted

imaging,”

“computed

tomography,”

lavage,”

“bronchoalveolar

“corticosteroid,”

“

methylprednisolone,” “ARDS,” and

ECMO.”

“

cohorts,

case-control

studies,

For contemporary epidemiology,

priority was given to large trauma

datasets and cohorts published after

the end date of the historical

systematic review. For diagnosis and

diagnostic cohorts, case series with

at least five patients, and high-quality

systematic reviews/meta-analyses

were considered. Isolated case

reports, nontraumatic FES, elective

arthroplasty-only studies, animal

studies, and publications without

usable clinical outcomes were

treatment,

primary

diagnostic

studies, randomized or comparative

intervention studies, and systematic

reviews/meta-analyses were used to

identify the most reproducible

findings and to avoid over-weighting

isolated case reports. Recent case

series were used only when they

excluded

synthesis, although exceptional

rescue-therapy reports were

from

the

principal

discussed as very-low-certainty

evidence.

provided

clinically

relevant

8

24

Revista Científica Multidisciplinaria Arbitrada YACHASUN. Volumen 10, Número 19 (Ed. jul – dic. 2026) ISSN: 2697-3456

Fat embolism syndrome after femoral fracture: early recognition, diagnostic confirmation, and therapeutic strategy.

2

.4 Data extraction and synthesis

standard, incidence estimates were

not pooled across studies with

different case definitions. Diagnostic

Data were extracted into domain-

specific evidence tables capturing

study design, population, fracture

pattern, FES definition, timing,

diagnostic findings, intervention, and

outcomes. Eligibility and numerical

results were cross-checked against

PubMed records or accessible full

text when available. Given the

absence of a validated reference

evidence

was

interpreted

as

supportive rather than as formal

diagnostic-accuracy meta-analysis.

Certainty was graded qualitatively as

moderate, low, or very low according

to study design, consistency,

directness, precision, and risk of

misclassification.

Figure 1. Evidence-base assembly for this updated systematic review and clinical synthesis.

fracture systematic review (n=3,095),

3

. Results

incidence fell from 7.9% in studies

3

.1 Incidence, temporal trends,

from 1960–1979 to 4.8% in 1980–

and high-risk phenotypes

1

999 and 1.7% in 2000–2019. [3] In

a US National Hospital Discharge

Survey analysis, FES was recorded

in 0.12% of patients with isolated at-

risk fractures overall, but occurred

The strongest consistent finding is

that reported FES incidence is highly

dependent on how the syndrome is

defined. In the 15-study femoral-

8

25

Macias-Narvaez et al. (2026)

more often with multiple femoral

fractures than isolated femoral

fractures. [4] A 2020 Trauma Quality

Improvement Program analysis of

displacement, and polytrauma. [3,5–

9] The 2017 Brazilian femoral-shaft

cohort documented six FES cases

among 272 patients and found

3

24,165 patients with extremity

polytrauma,

rather

than

the

fractures identified only 116 coded

FES cases (0.04%), whereas a 2024

National Trauma Data Bank study

identified 344 FES cases among

provisional fixation method itself, to

be the main correlate. [9] Historical

trauma-center experience similarly

associated clinically overt FES with

greater injury burden. [8]

1

,251,143 patients (0.03%). [5,6]

These administrative estimates are

likely specific but may be insensitive

because the diagnosis depends on

coding and documentation.

3

.2 Timing and early clinical

recognition

The classic syndrome usually

appears after an initially stable

interval, most often within 12–72 h

A large contemporary single-center

trauma cohort from Bogotá provides

a contrasting estimate: among 3,475

adults with long-bone fractures, FES

occurred in 4.3% (n=148) with 5.4%

after

injury

or

orthopedic

manipulation. A fulminant form can

occur earlier and is characterized by

abrupt respiratory and right-heart

failure, but the more common pattern

is progressive hypoxemia followed

by neurologic dysfunction, fever,

tachycardia, thrombocytopenia or

anemia, and occasionally petechiae.

in-hospital

fracture

mortality.

was the

Femoral

strongest

independent risk factor (adjusted OR

.63, 95% CI 2.99–7.22), and early

fixation within 24 h was protective

adjusted OR 0.42, 95% CI 0.25–

.71). [7] This difference from

4

(

[

10–13] Clinicians should therefore

0

not wait for the complete triad before

escalating evaluation.

administrative datasets illustrates

why incidence should not be quoted

as one universal number.

In the 81-patient imaging-correlated

cohort by Shaikh et al., respiratory

insufficiency was present in 98%,

neurologic deterioration in 70%, but

petechial rash in only 2.5%. [13] This

Across studies, risk clusters around

younger age, femoral fracture,

bilateral or multiple long-bone

fractures, high-energy trauma, major

8

26

Revista Científica Multidisciplinaria Arbitrada YACHASUN. Volumen 10, Número 19 (Ed. jul – dic. 2026) ISSN: 2697-3456

Fat embolism syndrome after femoral fracture: early recognition, diagnostic confirmation, and therapeutic strategy.

reinforces two practical points:

hypoxemia is the most sensitive

bedside warning signal, and the

absence of petechiae does not

meaningfully exclude FES. Recent

small case series have similarly

emphasized

early

oxygen

desaturation, falling hemoglobin and

platelet counts, and inflammatory-

marker

rises,

but

biomarker

thresholds are not sufficiently

validated for diagnostic use. [30]

Table 1. Common diagnostic frameworks and their limitations.

Typical

threshold

Framework

Diagnostic components

Main limitation

Major: respiratory insufficiency with Historically No prospective

radiographic change; cerebral signs major, or 1 major validation; several items

unrelated to head injury; petechial minor are subjective or

rash. Minor findings include (variants exist). nonspecific;

tachycardia, fever, retinal/renal

Gurd–Wilson

2

+

4

performance depends

on how criteria are

operationalized.

changes, anemia, thrombocytopenia

and others.

Schonfeld score

Lindeque

Petechiae (5), diffuse chest infiltrates Score

>5 Semiquantitative but not

(4), hypoxemia (3), fever (1), commonly used. validated against an

tachycardia (1), tachypnea (1),

confusion (1).

accepted

standard.

reference

Physiologic respiratory criteria based At least one May increase sensitivity

on PaO₂, PaCO₂/pH, respiratory rate respiratory

but

over-calls

post-

respiratory

ignores

and respiratory distress.

criterion in the nonspecific

original proposal. traumatic

failure;

multisystem pattern.

Clinicoradiologic

approach

Compatible

unexplained

trauma

setting

+

No

single Most clinically realistic

approach, but still lacks

respiratory/neurologic numeric

deterioration + supportive imaging, threshold.

after exclusion of major mimics.

a

gold-standard

confirmatory test.

embolization but do not prove the

clinical syndrome. No circulating

lipid, lipase, inflammatory cytokine,

or other biomarker has reached

sufficient validation to serve as a

confirmatory test. Laboratory testing

is therefore best used to detect

3

.3 Diagnostic confirmation: what

adds value?

3

.3.1 Laboratory testing

Routine laboratory abnormalities—

falling

hemoglobin,

elevated

thrombocytopenia,

physiologic and

competing diagnoses rather than to

rule in” FES.

deterioration

inflammatory markers, hypoxemia on

arterial blood gas, and occasionally

coagulopathy—are common but

nonspecific. Fat globules in blood,

urine, or sputum indicate fat

“

8

27

Macias-Narvaez et al. (2026)

3

.3.2 Chest radiography and CT

diffusion, particularly in the acute

phase. [15,16] A systematic review of

cerebral FES imaging described five

evolving MRI patterns: scattered

Chest radiographs may show

bilateral diffuse or patchy infiltrates,

but these findings overlap with

pulmonary contusion, aspiration,

edema, pneumonia, transfusion-

associated lung injury, and ARDS

from other causes. Chest CT more

often demonstrates bilateral ground-

embolic

ischemia,

confluent

symmetric cytotoxic white-matter

edema, vasogenic edema, petechial

hemorrhage, and chronic sequelae.

[

15] Susceptibility-weighted imaging

can reveal numerous

glass ill-defined

centrilobular nodules, interlobular

septal thickening, or patchy

opacities,

microhemorrhagic foci that may be

more conspicuous than lesions on

conventional

Accordingly, DWI and SWI should be

included when unexplained

sequences.

consolidation. [14,28] In the Shaikh

cohort, CT demonstrated patchy

alveolar opacities in 60.5% of

neurologic deterioration persists

after femoral or multiple long-bone

trauma.

patients.

[13]

CT

pulmonary

when

angiography

is

useful

thrombotic pulmonary embolism

must be excluded, but a normal

pulmonary angiogram does not

exclude FES because the pathologic

3.3.4 Bronchoalveolar lavage and

other invasive tests

Bronchoalveolar lavage (BAL) has

repeatedly failed to provide adequate

specificity. Stanley et al. found lipid-

process predominantly

is

microvascular and inflammatory.

3

.3.3 Brain CT and MRI

laden macrophages above

proposed threshold in most non-FES

pulmonary patients, yielding

a

Neurologic FES is the setting in

which imaging is most likely to alter

diagnostic confidence. Head CT may

be normal or show nonspecific

cerebral edema. By contrast, brain

a

specificity of only 26.5%. [17] Roger

et al. similarly found Oil Red O-

positive macrophages in trauma

patients both with and without clinical

FES. [18] BAL may document

pulmonary fat exposure but should

not be used routinely to confirm FES.

MRI

can

demonstrate

a

characteristic “starfield” pattern of

multiple punctate foci of restricted

8

28

Revista Científica Multidisciplinaria Arbitrada YACHASUN. Volumen 10, Número 19 (Ed. jul – dic. 2026) ISSN: 2697-3456

Fat embolism syndrome after femoral fracture: early recognition, diagnostic confirmation, and therapeutic strategy.

Transesophageal echocardiography

and transcranial Doppler can

demonstrate embolic showers during

orthopedic procedures, yet these

techniques identify embolization

rather than the syndrome and are not

standard diagnostic tests for

postoperative deterioration.

Table 2. Representative evidence informing recognition, diagnosis, and risk stratification.

Study

Design / sample

Key finding

Interpretation

Lempert et al., Systematic review; 15 FES incidence declined from 7.9% Best historical synthesis;

2021 [3]

studies;

femoral-fracture

patients

n=3,095 (1960–1979) to 1.7% (2000–2019); substantial heterogeneity in

bilateral/pathologic injury patterns diagnostic definitions.

had higher rates than unilateral high-

energy fractures.

Alpert et al., 2020 TQIP cohort; n=324,165 116 coded FES cases (0.04%); age Large contemporary dataset;

[

5]

extremity-fracture

patients

≤30, closed femur fracture, and likely under-detection from

multiple long-bone fractures administrative coding.

associated with FES.

Owattanapanich et NTDB

al., 2024 [6]

study; FES associated with higher mortality Supports clinical relevance

n=1,251,143; 344 FES (7% vs 1% in matched comparison).

despite very low coded

incidence.

cases

Gavidia Bernal et Retrospective trauma FES 4.3%; femoral fracture aOR 4.63; Contemporary

clinically

cohort;

al., 2026 [7]

cohort; n=3,475

early fixation <24 h aOR 0.42; in- detected

hospital mortality 5.4%.

demonstrates case-definition

effect and protective

association of early fixation.

Shaikh et al., 2018 Clinical/imaging cohort; Respiratory

13] n=81 FES patients

insufficiency

98%, Useful description of real-

[

neurologic decline 70%, petechiae world presentation; lacks

.5%; CT chest opacities 60.5%; MRI independent gold standard.

starfield 28.4%.

2

Stanley et al., 1994 BAL specificity study; >5% lipid-laden BAL cells in 25/34; Strong argument against BAL

[

17]

n=34

pulmonary patients

non-FES specificity only 26.5%.

as a stand-alone diagnostic

test.

Roger et al., 1995 BAL study; trauma

+

Oil Red O-positive macrophages Fat-laden

occurred in trauma patients with and reflect

macrophages

[

18]

nontrauma controls

without FES.

embolization/exposure, not

necessarily clinical FES.

Pinney et al. reported FES in 11 of

3

.4 Prevention and timing of

2

74 isolated femoral-shaft fractures

fracture stabilization

(4% overall); among patients

The most consistent modifiable

strategy is timely stabilization of the

fracture, provided the patient’s

physiology permits definitive surgery.

In Svenningsen et al., delayed

fixation after 4–7 days was

associated with FES in 10.4% of

patients compared with 1.8% after

younger than 35 years, no cases

occurred in 60 patients nailed within

1

0 h, whereas 11 of 109 nailed after

developed FES. [11]

0

h

Contemporary cohort data also

support an association between

fixation within 24 h and reduced FES

risk. [7]

immediate

osteosynthesis.

[10]

8

29

Macias-Narvaez et al. (2026)

These data should not be interpreted

FES

events

with

as

a

mandate for immediate

methylprednisolone, although doses,

definitions, and trial quality varied

substantially. [21–24] In the 2004

Babalis trial, FES occurred in 2.5% of

the steroid group and 12.8% of

controls, but the difference did not

definitive intramedullary nailing in

every unstable polytrauma patient.

The modern principle is early

appropriate

care:

minimize

motion,

unnecessary

fracture

resuscitate promptly, and choose

definitive fixation versus damage-

control orthopedics according to

reach

conventional

statistical

significance (P=0.079). [24]

A

meta-analysis

of

seven

hemodynamic,

respiratory,

randomized trials (389 patients)

estimated a 78% relative reduction in

FES with corticosteroid prophylaxis

and a number needed to treat of 8,

while finding no significant mortality

or infection benefit. Importantly, the

authors rated the underlying trials as

methodologically weak and did not

metabolic, and associated-injury

status. Reviews of major long-bone

fracture management emphasize

that FES is multifactorial and cannot

be completely prevented by timing

alone. [12,32]

3

.5 Pharmacologic prophylaxis

and treatment

recommend

a

routine practice

change. [25] A separate meta-

analysis reached a similar conclusion

for FES and hypoxemia reduction.

3

.5.1 Corticosteroids

Corticosteroids have the largest

historical pharmacologic evidence

base, but most trials predate

contemporary trauma systems and

modern fixation techniques. In the

randomized double-blind Schonfeld

trial, FES occurred in 0 of 21

[

26] These data support biologic

plausibility and a preventive signal,

but not a contemporary standard of

care. Evidence for corticosteroids

after FES is already established is

even weaker and is dominated by

uncontrolled

reports;

therefore,

corticosteroid-treated

patients

routine therapeutic steroids cannot

be recommended solely for FES.

versus 9 of 41 placebo patients. [20]

Other trials by Alho, Stoltenberg,

Lindeque, and Babalis generally

reported less hypoxemia or fewer

8

30

Revista Científica Multidisciplinaria Arbitrada YACHASUN. Volumen 10, Número 19 (Ed. jul – dic. 2026) ISSN: 2697-3456

Fat embolism syndrome after femoral fracture: early recognition, diagnostic confirmation, and therapeutic strategy.

3

.5.2 Anticoagulation, albumin,

monitoring may be sufficient in mild

disease. Patients with ARDS should

receive lung-protective ventilation

and standard evidence-based ARDS

care. Hemodynamic support should

target adequate perfusion while

avoiding unnecessary fluid overload;

vasopressors and inotropes are used

when shock or right-ventricular

failure develops. Fever, seizures,

agitation, and secondary brain injury

should be treated conventionally.

and other agents

Heparin has been proposed because

it activates lipoprotein lipase, but

there is no convincing clinical

evidence

that

disease-specific

anticoagulation improves FES, and

trauma-related bleeding risk is

substantial. Anticoagulation should

therefore be prescribed for standard

indications

such

as

venous-

thromboembolism prophylaxis or

proven thrombotic embolism, not as

treatment for fat microembolization

itself. Albumin may be reasonable

when clinically indicated for volume

resuscitation because of free-fatty-

acid binding, but no high-quality trial

supports albumin as a disease-

specific therapy. Dextrose, ethanol,

dextran-based regimens, and other

historical approaches have not

become standard practice.

[

27,32]

For

refractory

hypoxemia

or

circulatory collapse, extracorporeal

membrane oxygenation (ECMO) has

been used successfully in highly

selected cases. Published evidence

remains limited to case reports and

small series, including recent VV-

ECMO and VA-ECMO rescue

experiences. [31] ECMO should

therefore be viewed as a rescue

option in expert centers rather than a

standard FES therapy, particularly

3

.5.3 Respiratory, neurologic, and

hemodynamic support

because

anticoagulation

and

bleeding risk are major concerns in

polytrauma.

Supportive critical care remains the

therapeutic

cornerstone.

Supplemental oxygen and close

Table 3. Therapeutic strategy and certainty of evidence.

Intervention

Evidence signal

fracture Historical comparative studies Moderate

when and contemporary cohort

Certainty

Practical recommendation

Early

Recommended as part of modern

trauma care; use damage-control

orthopedics if definitive fixation is

unsafe.

stabilization

physiologically

appropriate

associations consistently favor

earlier stabilization.

8

31

Macias-Narvaez et al. (2026)

Intervention

Oxygen

Evidence signal

lung- Universal

Certainty

Practical recommendation

/

supportive-care Moderate

Standard of care.

protective ventilation / principle; direct randomized FES (indirect)

standard ARDS care

trials are not feasible.

Corticosteroid

prophylaxis

Older randomized trials and Low

Do not use routinely; may be a

meta-analyses

show

fewer

research

decision.

or

protocolized-center

FES/hypoxemia events but no

proven mortality benefit; trials are

small and dated.

Corticosteroids

established FES

for Mostly uncontrolled reports; no Very low

robust randomized therapeutic

evidence.

Not recommended routinely solely for

FES.

Therapeutic heparin for No convincing clinical benefit; Very low

Do not use for FES alone. Use

anticoagulation only for standard

indications.

FES

meaningful bleeding risk in

trauma.

Albumin as disease- Physiologic rationale but no high- Very low

Use only when otherwise indicated for

resuscitation, not as specific FES

treatment.

specific therapy

quality clinical evidence.

ECMO

Case reports/small series in Very low

refractory ARDS or shock.

Rescue therapy in selected patients at

experienced centers.

by orders of magnitude and why no

disease-specific drug has achieved

broad guideline-level acceptance.

3

.6 Quality and limitations of the

evidence

The overall certainty of evidence is

limited by three recurring problems.

First, there is no accepted diagnostic

4

. Discussion

reference

standard,

so

both

This synthesis supports a practical

reframing of FES. The syndrome

should not be approached as a

diagnosis that requires the classic

triad or a single positive test. Instead,

clinicians should recognize a high-

risk context—especially femoral,

bilateral, or multiple long-bone

underdiagnosis and overdiagnosis

are plausible. Second, administrative

datasets achieve enormous sample

size at the cost of dependence on

coding,

whereas

clinically

adjudicated series are richer but

smaller and more vulnerable to

referral bias. Third, most randomized

corticosteroid trials are several

decades old, used heterogeneous

doses and diagnostic definitions, and

fractures—and then identify

a

dynamic change in oxygenation,

neurologic status, or systemic

physiology during the first 72 h. A

complete petechial eruption is

diagnostically helpful when present,

preceded

current

trauma

resuscitation, ventilatory care, and

fixation strategies. These limitations

explain why incidence estimates vary

8

32

Revista Científica Multidisciplinaria Arbitrada YACHASUN. Volumen 10, Número 19 (Ed. jul – dic. 2026) ISSN: 2697-3456

Fat embolism syndrome after femoral fracture: early recognition, diagnostic confirmation, and therapeutic strategy.

but it is too insensitive to be used as

a gatekeeper. [13]

hypoxemia as FES. Accordingly, the

diagnosis is best made through

temporal pattern recognition plus

exclusion of more common causes of

deterioration.

The large discrepancy between

modern administrative incidence

estimates and clinically adjudicated

trauma-center cohorts is not merely a

statistical nuisance; it reflects the

underlying diagnostic problem. [5–7]

A coded incidence of 0.03% should

not reassure clinicians that FES is

almost nonexistent, just as older

series reporting rates above 10%

should not be applied uncritically to

contemporary practice. The most

defensible interpretation is that

Imaging should be used strategically.

In a hypoxemic patient, chest CT can

support the diagnosis while CT

pulmonary

angiography

helps

evaluate thrombotic embolism, but

parenchymal opacities are not

pathognomonic. Neuroimaging is

more discriminating. In patients with

new confusion, seizures, decreased

consciousness, or focal neurologic

abnormalities unexplained by head

trauma or metabolic causes, MRI

with DWI and SWI materially

increases diagnostic confidence.

[15,16] The starfield pattern is not

present in every patient and evolves

with time, so a normal early

sequence does not entirely exclude

cerebral FES; however, when typical

lesions occur in the correct clinical

context, they provide the strongest

available confirmatory support.

clinically

significant

FES

is

uncommon, but risk is concentrated

in identifiable trauma phenotypes

and

the

syndrome

remains

consequential when it occurs.

Diagnostic criteria remain useful as

structured memory aids, not as

validated confirmatory tools. Gurd–

Wilson

multisystem concept but include

subjective and nonspecific

criteria

capture

the

components. Schonfeld provides a

semiquantitative score, yet has not

been prospectively validated against

a true reference standard. Lindeque

increases objectivity by emphasizing

respiratory physiology but can

classify nonspecific post-traumatic

Prevention and treatment should

remain

centered

on

trauma

fundamentals. Gentle handling and

prompt stabilization reduce ongoing

marrow disruption, while the timing

and technique of fixation must be

8

33

Macias-Narvaez et al. (2026)

individualized to physiology. [7,10–

continuous pulse oximetry during the

early post-injury period; (2) serial

respiratory rate, mental-status, skin,

and hemodynamic assessment; (3)

repeat hemoglobin and platelet

counts when clinical status changes;

(4) immediate arterial blood gas

analysis and chest imaging for

unexplained desaturation; (5) rapid

exclusion of hemorrhage, pulmonary

1

2] The corticosteroid literature is a

classic example of a statistically

positive but clinically unsettled

evidence base: pooled historical

trials suggest fewer FES events, yet

they are too small, heterogeneous,

and dated to support routine

prophylaxis in modern practice. [20–

2

6] A well-designed contemporary

multicenter trial would be required

before this question can be

considered resolved.

thromboembolism,

pulmonary contusion,

aspiration,

sepsis,

transfusion-related lung injury, and

intracranial injury; and (6) MRI brain

with DWI and SWI for persistent or

Once FES develops, high-quality

organ support is more important than

unproven disease-specific drugs.

This includes oxygenation, lung-

protective ventilation for ARDS,

hemodynamic stabilization, and

unexplained

neurologic

deterioration. This approach is

intentionally trigger-based rather

than dependent on waiting for a full

diagnostic score.

management

complications.

of

neurologic

Disease-specific

heparin is not justified. Rescue

ECMO may be lifesaving in

exceptional refractory cases, but the

evidence is necessarily very low

certainty and the bleeding risk of

extracorporeal support in trauma

must be considered. [31]

4

.1 Proposed first-72-hour

surveillance strategy

A practical surveillance protocol after

high-risk femoral fracture is: (1)

8

34

Revista Científica Multidisciplinaria Arbitrada YACHASUN. Volumen 10, Número 19 (Ed. jul – dic. 2026) ISSN: 2697-3456

Fat embolism syndrome after femoral fracture: early recognition, diagnostic confirmation, and therapeutic strategy.

Figure 2. Proposed clinical pathway for suspected FES after femoral fracture. The algorithm is

an evidence-informed synthesis rather than a validated prediction rule.

literature through August 2026. It

4

.2 Strengths and limitations of

also separates fat embolization from

the clinical syndrome and avoids

treating any single clinical score or

imaging sign as a gold standard.

Limitations include the use of an

update strategy rather than a

completely de novo search of every

this review

The main strength of this review is

integration of historical femoral-

fracture evidence with very large

contemporary trauma datasets and

focused diagnostic and therapeutic

8

35

Macias-Narvaez et al. (2026)

subscription database, the lack of

prospective protocol registration,

substantial overlap among historical

evidence syntheses, and the

impossibility of formal diagnostic-

accuracy pooling in the absence of a

reference standard. Publication bias

is especially relevant to cerebral FES

and ECMO rescue reports. These

limitations should be stated explicitly

rather than hidden by an artificial

pooled estimate.

sufficiently specific for routine

diagnostic use. Treatment should

prioritize oxygenation, lung-

protective ventilation when required,

hemodynamic

support, and

and

timely

neurologic

fracture

stabilization according to the

patient’s physiologic state. Historical

corticosteroid

prophylactic

trials

suggest

but are

benefit

insufficient to support routine modern

use, and there is no evidence base

for disease-specific heparin. ECMO

is reserved for refractory respiratory

or circulatory failure in selected

patients. A structured first-72-hour

surveillance pathway is the most

immediately actionable strategy for

reducing delayed recognition.

5

. Conclusiones

Fat embolism syndrome after

femoral fracture remains uncommon

but clinically important. The highest-

risk phenotype includes younger

patients with high-energy femoral,

bilateral, or multiple long-bone

fractures and substantial injury

burden. New hypoxemia and

neurologic deterioration during the

Bibliografía

1

. Gurd AR. Fat embolism: an aid to

diagnosis. J Bone Joint Surg

Br.

doi:10.1302/0301-

20X.52B4.732.

1970;52(4):732-737.

first 12–72

h

should trigger

6

immediate evaluation even in the

absence of petechiae. No diagnostic

criterion or laboratory test is

definitive. Chest CT is supportive and

useful for differential diagnosis, while

brain MRI with DWI and SWI offers

the most specific imaging support for

2

3

. Gurd AR, Wilson RI. The fat

embolism syndrome. J Bone

Joint

Surg

Br.

1

974;56B(3):408-416.

. Lempert M, Halvachizadeh S,

Ellanti P, Pfeifer R, Hax J,

Jensen KO, et al. Incidence of

fat embolism syndrome in

femur fractures and its

cerebral

involvement.

Bronchoalveolar lavage is not

8

36

Revista Científica Multidisciplinaria Arbitrada YACHASUN. Volumen 10, Número 19 (Ed. jul – dic. 2026) ISSN: 2697-3456

Fat embolism syndrome after femoral fracture: early recognition, diagnostic confirmation, and therapeutic strategy.

associated risk factors over

time—a systematic review. J

Clin Med. 2021;10(12):2733.

doi:10.3390/jcm10122733.

doi:10.1007/s00068-026-

03104-9.

8

. Bulger EM, Smith DG, Maier RV,

Jurkovich GJ. Fat embolism

syndrome: a 10-year review.

Arch Surg. 1997;132(4):435-

439.

4

5

. Stein PD, Yaekoub AY, Matta F,

Kleerekoper M. Fat embolism

syndrome. Am J Med Sci.

2

008;336(6):472-477.

doi:10.1097/MAJ.0b013e318

72f5d2.

doi:10.1001/archsurg.1997.0

1430280109019.

1

9

. Silva JJAB, Diana DA, Salas VER,

Zamboni C, Hungria Neto JS,

Christian RW. Fat embolism

syndrome in femoral shaft

fractures: does the initial

treatment make a difference?

. Alpert M, Grigorian A, Scolaro J,

Learned J, Dolich M, Kuza

CM, et al. Fat embolism

syndrome in blunt trauma

patients

fractures.

2

with

J

extremity

Orthop.

Rev Ortop.

2017;52(5):535-537.

doi:10.1016/j.rboe.2016.08.0

1.

Bras

020;21:475-480.

doi:10.1016/j.jor.2020.08.040.

2

6

. Owattanapanich N, Lewis M,

Biswas S, Benjamin ER,

Demetriades D. Epidemiology

and risk factors for fat

embolism in isolated lower

extremity long bone fractures.

Eur J Trauma Emerg Surg.

10. Svenningsen S, Nesse O, Finsen

V, Hole A, Benum P.

Prevention of fat embolism

syndrome in patients with

femoral fractures—immediate

or delayed operative fixation?

2

024;50(4):1775-1781.

doi:10.1007/s00068-024-

2516-9.

Ann

Chir

Gynaecol.

1987;76(3):163-166.

0

1

1. Pinney SJ, Keating JF, Meek RN.

Fat embolism syndrome in

isolated femoral fractures:

7

. Gavidia Bernal OY, Clavijo Lozano

NR, Bello Cordero JF, Avila

Tenjo

EA,

Lazaro

JS,

does

timing

of

nailing

Bermúdez Acosta DC, et al.

Incidence, mortality, and

factors associated with fat

influence incidence? Injury.

1998;29(2):131-133.

doi:10.1016/S0020-

embolism

syndrome

in

1383(97)00154-X.

patients with long bone

fractures at a trauma referral

center in Bogotá, Colombia:

1

2. Blokhuis TJ, Pape HC, Frölke

JPM. Timing of definitive

fixation of major long bone

fractures: can fat embolism

syndrome be prevented?

2

016–2019 and 2022–2023.

Eur J Trauma Emerg Surg.

026;52:120.

2

8

37

Macias-Narvaez et al. (2026)

Injury. 2017;48 Suppl 1:S3-

S6.

doi:10.1016/j.injury.2017.04.0

17. Stanley JD, Hanson RR, Hicklin

GA, Glazier AJ Jr, Ervanian A,

Jadali M. Specificity of

bronchoalveolar lavage for the

diagnosis of fat embolism

1

5.

1

3. Shaikh N, Mahmood Z, Ghuori

SI, Chanda A, Ganaw A,

Zeeshan Q, et al. Correlation

of clinical parameters with

imaging findings to confirm the

diagnosis of fat embolism

syndrome.

Am

Surg.

1

994;60(7):537-541.

18. Roger N, Xaubet A, Agustí C,

Zabala E, Ballester E, Torres

A,

et

al.

Role

of

syndrome. Int

Trauma. 2018;8(5):135-144.

J

Burns

bronchoalveolar lavage in the

diagnosis of fat embolism

syndrome. Eur Respir J.

1

4. Newbigin K, Souza CA, Torres C,

Marchiori E, Gupta A, Inacio J,

et al. Fat embolism syndrome:

1

995;8(8):1275-1280.

doi:10.1183/09031936.95.08

81275.

0

state-of-the-art

focused on

review

pulmonary

19. Reider E, Sherman Y, Weiss Y,

Liebergall M, Pizov R.

Alveolar macrophages fat

stain in early diagnosis of fat

embolism syndrome. Isr J

Med Sci. 1997;33(10):654-

imaging findings. Respir Med.

016;113:93-100.

doi:10.1016/j.rmed.2016.01.0

8.

2

1

5. Kuo KH, Pan YJ, Lai YJ, Cheung

WK, Chang FC, Jarosz J.

Dynamic MR imaging patterns

of cerebral fat embolism: a

6

58.

20. Schonfeld SA, Ploysongsang Y,

DiLisio R, Crissman JD, Miller

E, Hammerschmidt DE, et al.

Fat embolism prophylaxis with

corticosteroids: a prospective

study in high-risk patients.

systematic

review

with

illustrative cases. AJNR Am J

Neuroradiol.

2

014;35(6):1052-1057.

doi:10.3174/ajnr.A3605.

Ann Med.

983;99(4):438-443.

doi:10.7326/0003-4819-99-4-

38.

Intern

1

6. Parizel PM, Demey HE,

Veeckmans G, Verstreken F,

Cras P, Jorens PG, et al. Early

diagnosis of cerebral fat

4

21. Lindeque BG, Schoeman HS,

Dommisse GF, Boeyens MC,

Vlok AL. Fat embolism and the

fat embolism syndrome: a

embolism

syndrome

by

MRI

diffusion-weighted

(

2

starfield pattern). Stroke.

001;32(12):2942-2944.

PMID:11740000.

double-blind

study. J Bone Joint Surg Br.

987;69(1):128-131.

therapeutic

1

8

38

Revista Científica Multidisciplinaria Arbitrada YACHASUN. Volumen 10, Número 19 (Ed. jul – dic. 2026) ISSN: 2697-3456

Fat embolism syndrome after femoral fracture: early recognition, diagnostic confirmation, and therapeutic strategy.

doi:10.1302/0301-

20X.69B1.3818718.

doi:10.1590/S1806-

37132008000100007.

6

2

2. Alho A, Saikku K, Eerola P,

Koskinen M, Hämäläinen M.

Corticosteroids in patients

with a high risk of fat embolism

syndrome. Surg Gynecol

Obstet. 1978;147(3):358-362.

27. Luff D, Hewson DW. Fat

embolism syndrome. BJA

Educ.

2021;21(9):322-328.

doi:10.1016/j.bjae.2021.04.00

3.

2

8. Qi M, Zhou H, Yi Q, Wang M,

Tang Y. Pulmonary CT

imaging findings in fat

embolism syndrome: case

series and literature review.

3. Stoltenberg JJ, Gustilo RB. The

use of methylprednisolone

and hypertonic glucose in the

prophylaxis of fat embolism

syndrome. Clin Orthop Relat

Res. 1979;(143):211-221.

Clin (Lond).

2023;23(1):88-93.

doi:10.7861/clinmed.2022-

428.

Med

4. Babalis GA, Yiannakopoulos CK,

Karliaftis K, Antonogiannakis

E. Prevention of posttraumatic

hypoxaemia in isolated lower

limb long bone fractures with a

minimal prophylactic dose of

0

29. Kalbas Y, Seaver T, Kumabe Y,

Halvachizadeh S, Lempert M,

Pfeifer R, et al. Fat embolism

syndrome in patients with

bilateral femur fractures: a

systematic review and case

corticosteroids.

004;35(3):309-317.

doi:10.1016/S0020-

383(03)00056-1.

Injury.

2

comparison.

2022;5(2

OTA Int.

Suppl):e187.

1

doi:10.1097/OI9.0000000000

00187.

2

5. Bederman SS, Bhandari M,

McKee MD, Schemitsch EH.

Do corticosteroids reduce the

risk of fat embolism syndrome

in patients with long-bone

fractures? A meta-analysis.

Can J Surg. 2009;52(5):386-

0

30. Borgohain B, Naveen AS,

Khonglah TG. Fat embolism

syndrome: a case series from

a single tertiary care hospital.

J

Orthop Rep.

2026;16(6):182-188.

doi:10.13107/jocr.2026.v16.i0

.7418.

Case

3

93.

2

6. Cavallazzi R, Cavallazzi AC. The

effect of corticosteroids on the

prevention of fat embolism

syndrome after long bone

fracture of the lower limbs: a

systematic review and meta-

analysis. J Bras Pneumol.

6

31. Kasahara S, Maruhashi T,

Akinaga S, Takahashi A,

Okazaki K, Oi M, et al. Fat

embolism syndrome following

severe blunt chest trauma

treated with veno-venous

2

008;34(1):34-41.

8

39

Macias-Narvaez et al. (2026)

extracorporeal

membrane

oxygenation: a case report.

Trauma Case Rep.

025;60:101259.

2

doi:10.1016/j.tcr.2025.101259

.

3

2. White T, Petrisor BA, Bhandari

M. Prevention of fat embolism

syndrome. Injury. 2006;37

Suppl

doi:10.1016/j.injury.2006.08.0

1.

4:S59-S67.

4

3. He Z, Shi Z, Li C, Ni L, Sun Y,

Arioli F, et al. Single-case

metanalysis of fat embolism

syndrome. Int Cardiol.

021;345:111-117.

doi:10.1016/j.ijcard.2021.10.1

1.

J

2

5

8

40